TY  - GEN
AU  - Goey,K K H
AU  - Elias,S G
AU  - van Tinteren,H
AU  - Laclé,M M
AU  - Willems,S M
AU  - Offerhaus,G J A
AU  - de Leng,W W J
AU  - Strengman,E
AU  - Ten Tije,A J
AU  - Creemers,G-J M
AU  - van der Velden,A
AU  - de Jongh,F E
AU  - Erdkamp,F L G
AU  - Tanis,B C
AU  - Punt,C J A
AU  - Koopman,M
TI  - Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study
SN  - 1569-8041
PY  - 2018///0523
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - administration & dosage
KW  - Brain Neoplasms
KW  - genetics
KW  - Capecitabine
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - DNA Mismatch Repair
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Neoplastic Syndromes, Hereditary
KW  - Observation
KW  - Proto-Oncogene Proteins B-raf
KW  - Treatment Outcome
KW  - ras Proteins
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1093/annonc/mdx322
ER  -